About

Fran DeGrazio is an independent advisor to C-Suite and Senior Executives. Since late 2022, she has also served as a Kymanox Executive Advisor (KEA), having retired from her role as Chief Scientific Officer at West Pharmaceutical Services, which she joined as a chemist in 1983.

Ms DeGrazio has more than 35 years of experience in the life sciences industry including extensive expertise in sterile drug product systems, including vial container closure systems and prefillable syringes for combination products. She has published numerous technical articles and book chapters, and was a recipient of the PDA Packaging Science Award in 2021, the Philadelphia Business Journal 2018 Healthcare Innovators of the Greater Philadelphia Region Award and the Healthcare Businesswoman’s Association Luminary Award for West in 2017.

Contributions

INTERVIEW

Interview: Kymanox Executive Advisors Mathias Romacker, Fran DeGrazio & Paul Jansen

Mathias Romacker, Fran DeGrazio and Paul Jansen sit down with Guy Furness, to discuss what it is that has driven Kymanox’s rapid rise in the drug delivery space and what makes the consulting company’s model so successful, as well as to share their expertise on a variety of topics in an illuminating discussion, including connectivity, how large and small drug developers engage with consultancies, 5 mL autoinjectors and the interface between drug primary packaging and delivery devices.